Selling by month
Oct 2025 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.
Disclosed planOne dollar scale for every month; the tallest bar is labeled
Pattern
What the filings show, past 12 months. Nothing here rates or predicts.
- Sold in 2 of the 13 calendar months from Oct 2025 to Oct 2026: Mar 2026 and Jul 2026.
- Largest single sale: $4.2M (64,921 shares) of BridgeBio Pharma, Inc. on Mar 4, 2026. Filing
- Last sale before this period: Aug 5, 2025.
Roles from filings
Every company we track where this person has filed, newest filing first.
| Company | Title | First filing | Latest filing |
|---|---|---|---|
| BridgeBio Pharma, Inc. (BBIO) | Director | Aug 26, 2021 | Jul 13, 2026 |
Recent filings
The last 3 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.
- Jul 9, 2026, BridgeBio Pharma, Inc.: sold 17,167 shares for $1.4M, under a disclosed plan; 17,167 shares acquired by exercising options. 1 filing: 1
- Jun 22, 2026, BridgeBio Pharma, Inc.: 3,990 shares granted. 1 filing: 1
- Mar 4, 2026, BridgeBio Pharma, Inc.: sold 64,921 shares for $4.2M, under a disclosed plan; 64,921 shares acquired by exercising options. 1 filing: 1
This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.